Products
|
View: All | A | B | C | D | E | F | I | K | L | M | N | O | P | Q | R | S | T | U | V | X | Z |
||||||
| C | ||||||
|---|---|---|---|---|---|---|
| show more | Coumadin warfarin sodium |
Therapeutic Area: |
 
|
|||
|
|
Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website. Main Indication:
COUMADIN is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism. COUMADIN is indicated for the prophylaxis andor treatment of the thromboembolic complications associated with atrial fibrillation. COUMADIN is not indicated in patients with lone atrial fibrillation who are less than 60 years of age with no risk factors (eg previous thromboembolism (TIA, ischaemic stroke), diabetes mellitus, hypertension) and an otherwise normal heart. COUMADIN is indicated for use as an adjunct in the treatment of coronary occlusion.
|
|||||
